These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 20940070)

  • 1. Risks for cardiovascular disease, stroke, ischaemic heart disease, and diabetes mellitus associated with the metabolic syndrome using the new harmonised definition: findings from nationally representative longitudinal data from an Asian population.
    Khang YH; Cho SI; Kim HR
    Atherosclerosis; 2010 Dec; 213(2):579-85. PubMed ID: 20940070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome and the risk of ischemic heart disease and stroke among Japanese men and women.
    Iso H; Sato S; Kitamura A; Imano H; Kiyama M; Yamagishi K; Cui R; Tanigawa T; Shimamoto T
    Stroke; 2007 Jun; 38(6):1744-51. PubMed ID: 17431205
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic syndrome risk for cardiovascular disease and diabetes in the ARIC study.
    Ballantyne CM; Hoogeveen RC; McNeill AM; Heiss G; Schmidt MI; Duncan BB; Pankow JS
    Int J Obes (Lond); 2008 May; 32 Suppl 2(Suppl 2):S21-4. PubMed ID: 18469836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is poor oral health a risk marker for incident cardiovascular disease hospitalisation and all-cause mortality? Findings from 172 630 participants from the prospective 45 and Up Study.
    Joshy G; Arora M; Korda RJ; Chalmers J; Banks E
    BMJ Open; 2016 Aug; 6(8):e012386. PubMed ID: 27577588
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clothing size as an indicator of adiposity, ischaemic heart disease and cardiovascular risks.
    Han TS; Gates E; Truscott E; Lean ME
    J Hum Nutr Diet; 2005 Dec; 18(6):423-30. PubMed ID: 16351701
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparison of predictability of cardiovascular events between each metabolic component in patients with metabolic syndrome based on the revised National Cholesterol Education Program criteria.
    Hwang IC; Kim KK; Jee SH; Kang HC
    Yonsei Med J; 2011 Mar; 52(2):220-6. PubMed ID: 21319338
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic Syndrome and the Risk of Ischemic Heart Disease and Stroke among Middle-Aged Japanese.
    Chei CL; Yamagishi K; Tanigawa T; Kitamura A; Imano H; Kiyama M; Sato S; Iso H
    Hypertens Res; 2008 Oct; 31(10):1887-94. PubMed ID: 19015596
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical value of metabolic syndrome and risks of cardiometabolic events and mortality in the elderly: the Rotterdam study.
    van Herpt TT; Dehghan A; van Hoek M; Ikram MA; Hofman A; Sijbrands EJ; Franco OH
    Cardiovasc Diabetol; 2016 Apr; 15():69. PubMed ID: 27117940
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age-associated increase in abdominal obesity and insulin resistance, and usefulness of AHA/NHLBI definition of metabolic syndrome for predicting cardiovascular disease in Japanese elderly with type 2 diabetes mellitus.
    Sakurai T; Iimuro S; Araki A; Umegaki H; Ohashi Y; Yokono K; Ito H
    Gerontology; 2010; 56(2):141-9. PubMed ID: 19828932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estimating change in cardiovascular disease and diabetes burdens due to dietary and metabolic factors in Korea 1998-2011: a comparative risk assessment analysis.
    Cho Y; Cudhea F; Park JH; Lee JT; Mozaffarian D; Singh G; Shin MJ
    BMJ Open; 2016 Dec; 6(12):e013283. PubMed ID: 28003293
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypertension: its prevalence and population-attributable fraction for mortality from cardiovascular disease in the Asia-Pacific region.
    Martiniuk AL; Lee CM; Lawes CM; Ueshima H; Suh I; Lam TH; Gu D; Feigin V; Jamrozik K; Ohkubo T; Woodward M;
    J Hypertens; 2007 Jan; 25(1):73-9. PubMed ID: 17143176
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial.
    Scott R; Donoghoe M; Watts GF; O'Brien R; Pardy C; Taskinen MR; Davis TM; Colman PG; Manning P; Fulcher G; Keech AC;
    Cardiovasc Diabetol; 2011 Nov; 10():102. PubMed ID: 22104275
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Psoriasis, metabolic syndrome and cardiovascular risk factors. A population-based study.
    Fernández-Armenteros JM; Gómez-Arbonés X; Buti-Soler M; Betriu-Bars A; Sanmartin-Novell V; Ortega-Bravo M; Martínez-Alonso M; Garí E; Portero-Otín M; Santamaria-Babi L; Casanova-Seuma JM
    J Eur Acad Dermatol Venereol; 2019 Jan; 33(1):128-135. PubMed ID: 29953676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Atorvastatin efficacy in the prevention of cardiovascular events in patients with diabetes mellitus and/or metabolic syndrome.
    Arca M
    Drugs; 2007; 67 Suppl 1():43-54. PubMed ID: 17910520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Health and mortality consequences of abdominal obesity: evidence from the AusDiab study.
    Cameron AJ; Dunstan DW; Owen N; Zimmet PZ; Barr EL; Tonkin AM; Magliano DJ; Murray SG; Welborn TA; Shaw JE
    Med J Aust; 2009 Aug; 191(4):202-8. PubMed ID: 19705980
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular health status and metabolic syndrome in Ecuadorian natives/Mestizos aged 40 years or more with and without stroke and ischemic heart disease--an atahualpa project case-control nested study.
    Del Brutto OH; Mera RM; Montalván M; Del Brutto VJ; Zambrano M; Santamaría M; Tettamanti D
    J Stroke Cerebrovasc Dis; 2014 Apr; 23(4):643-8. PubMed ID: 23834848
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of the metabolic syndrome and its components on the incidence of ischemic heart disease and stroke: the Japan public health center-based study.
    Noda H; Iso H; Saito I; Konishi M; Inoue M; Tsugane S;
    Hypertens Res; 2009 Apr; 32(4):289-98. PubMed ID: 19262490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improved trends in cardiovascular complications among subjects with type 2 diabetes in Korea: a nationwide study (2006-2013).
    Jung CH; Chung JO; Han K; Ko SH; Ko KS; Park JY;
    Cardiovasc Diabetol; 2017 Jan; 16(1):1. PubMed ID: 28057001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Prevalence of Metabolic Syndrome and Its Related Risk Complications among Koreans.
    Lee SH; Tao S; Kim HS
    Nutrients; 2019 Jul; 11(8):. PubMed ID: 31366117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of the metabolic syndrome diagnosed using three different definitions and risk of ischemic heart disease among Kaunas adult population.
    Luksiene DI; Baceviciene M; Tamosiūnas A; Cerniauskiene LR; Margeviciene L; Reklaitiene R
    Medicina (Kaunas); 2010; 46(1):61-9. PubMed ID: 20234165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.